Down's Syndrome Screening Using Free βhCG: Instability Can Significantly Increase the Down's Risk Estimate
- 1 November 1996
- journal article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 33 (6) , 525-529
- https://doi.org/10.1177/000456329603300606
Abstract
The stability of free βhCG (human chorionic gonadotrophin) was assessed using a dual α-fetoprotein and free βhCG assay. A significant increase in free βhCG concentration was observed in heparinized samples left unseparated for 24 h or more, the mean increase in 21 samples being 10.2% after 24 h ( P = < 0.001), increasing to 45.7% after 96 h. Similar results were also obtained in clotted samples. The effect of the increase in free βhCG on the Down's risk estimate was calculated to assess the impact of delayed sample transport and separation. The Down's risk increased in all samples with increasing separation time, but this was most significant in two samples where, using a cut off of one in 250, the risk classification changed from low risk to high risk. These results suggest that delayed sample separation can have a significant effect on screening programmes using free βhCG, particularly with respect to those patients whose risk classification is changed.Keywords
This publication has 13 references indexed in Scilit:
- The effect of thermal instability of intact human chorionic gonadotropin (ihcg) on the application of its free β‐subunit (free βhcg) as a serum marker in down syndrome screeningPrenatal Diagnosis, 1995
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Maternal Serum-Free β-Human Chorionic Gonadotropin Level: The Effect of Sample TransportationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- Serum Free β-Human Chorionic Gonadotrophin Concentrations Increase in Unseparated Blood SpecimensAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1993
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndromeClinical Chemistry, 1991
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990
- The Mathematical Basis of Multivariate Risk Screening: With Special Reference to Screening for Down's Syndrome Associated PregnancyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988